跳至主要内容
临床试验/NCT02743832
NCT02743832招募中不适用

A Randomized,Multicenter,Prospectie,Controlled Clinical Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.

Jinsong Hou1 个研究点 分布在 1 个国家目标入组 524 人开始时间: 2026年5月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
524
试验地点
1
主要终点
Disease free survival

研究概览

简要总结

The purpose of this study is to determine whether cervical lymph node dissection is necessarily performed in the presence of early-stage oral squamous cell carcinoma.

详细描述

Oral squamous cell carcinoma is the most common malignant tumor of oral and maxillofacial region, and prone to early cervical lymph node metastases. Lymphatic spread is associated with increased risk of loco-regional recurrence, therefore, the identification of lymph node metastases preoperatively is very important for the optimal surgical therapy. Recently, cervical lymph node dissection(CLND) is performed in the presence of oral squamous cell carcinoma. However, whether cervical lymph node dissection is necessarily performed in the presence of early-stage oral squamous cell carcinoma is still controversial. CLND will represent over-treatment in some case of early-stage oral squamous cell carcinoma. Therefore, How to accurately predict whether a patient should be performed CLND is important. Our previous study show that tumor budding is closely related to lymphatic spread in the oral squamous cell carcinoma. The purpose of this study is to find that whether the tumor budding guide the individualized surgical planning of early-stage oral squamous cell carcinoma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Oral squamous cell carcinoma is confirmed by pathology;
  • The section of oral squamous cell carcinoma including primary two-thirds prior to the tongue, buccal mucosa, gingiva, mouth floor, hard palate mucosa;
  • The primary lesion is no more than 4cm;
  • Do not find cervical lymph node metastases and distant metastasis in the clinical examination including physical examination and MRI;
  • Patients and families agree to participate in the study;
  • Patients do not have cognitive disorders.

排除标准

  • Do not meet the inclusion criteria;
  • The primary lesion is more than 4cm or invade adjacent tissues;
  • Do not review on schedule;
  • Patients receive not only surgical procedures, but other antineoplastic treatment;
  • There are serious adverse events after operation;
  • Patients quit the study voluntarily;
  • Patients quit the study because of physical condition.

研究组 & 干预措施

Low-level tumor budding group without CLND

Experimental

Only resection for primary lesion is performed in the early-stage oral squamous cell carcinoma which tumor budding is a low level.

干预措施: Resection for primary lesion only (Procedure)

High-level tumor budding group with CLND

Experimental

Resection for primary lesion and cervical lymph node dissection (CLND) are performed in the early-stage oral squamous cell carcinoma which tumor budding is a high level.

干预措施: Resection for primary lesion and cervical lymph node dissection (Procedure)

High-level tumor budding group without CLND

Experimental

Only resection for primary lesion is performed in the early-stage oral squamous cell carcinoma which tumor budding is a high level.

干预措施: Resection for primary lesion only (Procedure)

Low-level tumor budding group with CLND

Experimental

Resection for primary lesion and cervical lymph node dissection (CLND) are performed in the early-stage oral squamous cell carcinoma which tumor budding is a low level.

干预措施: Resection for primary lesion and cervical lymph node dissection (Procedure)

结局指标

主要结局

Disease free survival

时间窗: After the first year, review every three months at a time;The next four years, review every six months at a time.

The time from the start of surgery to the discovery of the first cervical lymphatic metastases

Five-year survival rate

时间窗: After the first year, review every three months at a time;The next four years, review every six months at a time.

The time from the first operation to death was recorded

次要结局

  • Recurrence rate(After the first year, review every three months at a time;The next four years, review every six months at a time.)
  • Evaluation of quality of life(After the first year, review every three months at a time;The next four years, review every six months at a time.)

研究者

发起方
Jinsong Hou
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jinsong Hou

Vice Director

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验

A Study on Tumor Budding Guiding Individualized... | 临床试验